Related Experiment Videos
Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?
Journal of the National Cancer Institute
|February 14, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
1st International consensus guidelines for advanced breast cancer (ABC 1).
Breast (Edinburgh, Scotland)·2012
Markers of cervical intraepithelial neoplasia grade 2 regression and subsequent risk of CIN3.
Journal of the National Cancer Institute·2026
An artificial intelligence algorithm characterizes the deterioration of body composition from systemic therapy for patients with advanced prostate cancer.
Journal of the National Cancer Institute·2026
Obesity and survival of Asian American and White women with breast cancer.
Journal of the National Cancer Institute·2026
Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.
Journal of the National Cancer Institute·2026
Epstein-Barr virus-attributable cancers among children and adolescents in Europe and North America: a meta-analysis.
Journal of the National Cancer Institute·2026
Two-to-one randomization is associated with increased control-arm patient withdrawal.
Journal of the National Cancer Institute·2026